French Chemical Plant Vencorex Sold to Chinese Rival Wanhua, Triggering Outrage
The Lyon tribunal finalized the partial sale for €1.2 million, retaining only 50 jobs out of 450 and raising fears over industrial sovereignty and strategic supply chains.
- The tribunal of commerce in Lyon approved the partial acquisition of Vencorex by Chinese group Wanhua, via its Hungarian subsidiary BorsodChem, on April 10, 2025.
- The deal includes a sale price of €1.2 million, with Wanhua committing to invest €19 million in the site by 2027, but only 50 out of 450 jobs will be preserved.
- An employee-led cooperative bid, which aimed to save hundreds of jobs, was rejected due to insufficient financing and concerns over the site's short-term security.
- Political leaders and local officials criticized the decision, citing it as a blow to France's industrial sovereignty and a risk to supply chains in critical sectors like nuclear and aerospace.
- A proposal for temporary nationalization of Vencorex was previously rejected by the French government, further fueling criticism of inadequate intervention during the industrial crisis.
Marianne 
Le Journal du Dimanche 
l'Opinion 
Le Nouvel Obs 
La Croix 
L'Humanité 
Sud Ouest 